Services
Comprehensive pharmacology consulting services, including study design, execution oversight, data analysis, and preparation of summary reports and IND documents, to support the successful translation of preclinical data into early-phase clinical development.
Pharmacology Strategy Development
We deliver customized pharmacology strategies aligned with your modality’s mechanism of action and supported by diverse translational models—helping reduce risk and streamline the path to early clinical development.
Preclinical Data Packages
We integrate PK/PD, efficacy, and biomarker data into clear, actionable go/no-go recommendations.
Include benchmark studies of lead candidate molecules against competitor agents or the standard of care within a single study to enable fair comparison and decision making.
Clinical & Translational Strategy
Dose-response data support first-in-human (FIH) dose prediction. Integration of PK/PD informs clinical trial protocol design, including the optimal timing of PK and PD sample collection. Biomarker data guide the selection of endpoints for analysis.